|
US4130714A
(en)
|
1977-05-23 |
1978-12-19 |
Pfizer Inc. |
Hydantoin therapeutic agents
|
|
IE47592B1
(en)
|
1977-12-29 |
1984-05-02 |
Ici Ltd |
Enzyme inhibitory phthalazin-4-ylacetic acid derivatives, pharmaceutical compositions thereof,and process for their manufacture
|
|
JPS5745185A
(en)
|
1980-07-21 |
1982-03-13 |
Eisai Co Ltd |
Hydantoin derivative and its preparation
|
|
US4791126A
(en)
|
1980-08-22 |
1988-12-13 |
Ono Pharmaceutical Co., Ltd. |
Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredients
|
|
JPS5740478A
(en)
|
1980-08-22 |
1982-03-06 |
Ono Pharmaceut Co Ltd |
Rhodanine derivative, its preparation and aldose reductase inhibitor containing rhodanine derivative
|
|
CA1176269A
(en)
|
1981-03-02 |
1984-10-16 |
Kazimir Sestanj |
N-naphthoylglycine derivatives
|
|
US4436745A
(en)
|
1982-04-15 |
1984-03-13 |
Alcon Laboratories, Inc. |
Method of inhibiting aldose reductase activity
|
|
US4438272A
(en)
|
1982-04-15 |
1984-03-20 |
Alcon Laboratories, Inc. |
Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
|
|
US5066659A
(en)
|
1984-10-30 |
1991-11-19 |
Pfizer Inc. |
Spiro-heteroazalones for treatment of diabetic complications
|
|
GB8524663D0
(en)
|
1985-10-07 |
1985-11-13 |
Fujisawa Pharmaceutical Co |
Quinazoline derivatives
|
|
AU602641B2
(en)
|
1986-04-17 |
1990-10-18 |
Senju Pharmaceutical Co., Ltd. |
Thiolactam-N-acetic acid derivatives, their production and use
|
|
DE3769066D1
(de)
|
1986-08-28 |
1991-05-08 |
Sanwa Kagaku Kenkyusho Co |
Hydantoin-derivate zur behandlung von komplikationen bei diabetes.
|
|
GB8801037D0
(en)
|
1988-01-18 |
1988-02-17 |
Plessey Co Ltd |
Improvements relating to fuel supply systems
|
|
US5252572A
(en)
|
1988-02-03 |
1993-10-12 |
Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt. |
Pyridopyrimidine derivatives, pharmaceutical compositions containing them and process for preparing same
|
|
JPH03215435A
(ja)
*
|
1990-01-12 |
1991-09-20 |
Sanwa Kagaku Kenkyusho Co Ltd |
アルドース還元酵素阻害剤を主成分とする潰瘍治療剤
|
|
US4980357A
(en)
|
1990-03-01 |
1990-12-25 |
Pfizer Inc. |
Azolidinedione derivatives
|
|
US5037831A
(en)
|
1990-05-21 |
1991-08-06 |
American Home Products Corporation |
Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors
|
|
GB9016978D0
(en)
|
1990-08-02 |
1990-09-19 |
Ici Plc |
Acetamide derivatives
|
|
IL120264A0
(en)
|
1996-02-29 |
1997-06-10 |
Pfizer |
Method of reducing tissue damage associated with non-cardiac ischemia
|
|
US6696407B1
(en)
|
1997-03-21 |
2004-02-24 |
The Regents Of The University Of California |
Huntington's disease treatment comprising administering aldose reductase inhibitors to increase striatal CNTF
|
|
IL124236A
(en)
|
1997-05-05 |
2003-01-12 |
Pfizer |
Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
|
|
US6380200B1
(en)
|
1999-12-07 |
2002-04-30 |
Pfizer, Inc. |
Combination of aldose reductase inhibitors and selective serotonin reuptake inhibitors for the treatment of diabetic complications
|
|
GB2362101A
(en)
*
|
2000-05-12 |
2001-11-14 |
Astrazeneca Ab |
Treatment of chronic obstructive pulmonary disease
|
|
AP2001002359A0
(en)
|
2000-11-30 |
2001-12-31 |
Pfizer Prod Inc |
Combination of gaba agonists and aldose reductase inhibitors.
|
|
TW200408407A
(en)
*
|
2001-11-30 |
2004-06-01 |
Dana Farber Cancer Inst Inc |
Methods and compositions for modulating the immune system and uses thereof
|
|
WO2003105864A1
(en)
|
2002-06-13 |
2003-12-24 |
Board Of Regents, The University Of Texas System |
Methods and compositions involving aldose reductase inhibitors
|
|
US20070021366A1
(en)
|
2004-11-19 |
2007-01-25 |
Srivastava Satish K |
Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
|
|
US20100022625A1
(en)
|
2006-06-29 |
2010-01-28 |
Srivastava Satish K |
Structural-based inhibitors of the glutathione binding site in aldose reductase, methods of screening therefor and methods of use
|
|
US7702430B2
(en)
|
2004-11-19 |
2010-04-20 |
The Board Of Regents Of The University Of Texas System |
Method for designing a potential inhibitor of glutathione-aldehyde conjugate binding to aldose reductase
|
|
US20110092566A1
(en)
|
2004-11-19 |
2011-04-21 |
Srivastava Satish K |
Treatment of cancer with aldose reductase inhibitors
|
|
EP1982189A4
(en)
*
|
2006-01-27 |
2010-09-08 |
Univ Leland Stanford Junior |
COMPOSITIONS AND METHODS FOR SCREENING WITH HIGH PASSAGE OF PHARMACOLOGICAL CHAPTERS
|
|
CA2685202C
(en)
*
|
2007-03-23 |
2017-11-28 |
The Board Of Regents Of The University Of Texas System |
Methods for treating allergic asthma
|
|
US20090270490A1
(en)
|
2008-04-24 |
2009-10-29 |
The Board Of Regents Of The University Of Texas System |
Methods involving aldose reductase inhibition
|